The risk of infection associated with tumor necrosis factor α antagonists: Making sense of epidemiologic evidence

Daniel H. Solomon, Mark Lunt, Sebastian Schneeweiss

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)919-928
Number of pages9
JournalArthritis Care & Research
Volume58
Issue number4
DOIs
Publication statusPublished - Apr 2008

Keywords

  • SERIOUS BACTERIAL-INFECTIONS
  • MODIFYING ANTIRHEUMATIC DRUGS
  • RHEUMATOID-ARTHRITIS
  • PROPENSITY SCORE
  • FACTOR THERAPY
  • EVENTS

Cite this